Indian Generic Drug Company Cipla Receives FDA Approval For U.S. Sale Of Antiretroviral Zidovudine (Medical News Today)
Indian generic pharmaceutical company Cipla recently received full FDA approval to sell and market in the U.S. an oral generic version of the antiretroviral drug zidovudine, the Drug Industry Daily reports. Cipla's application for zidovudine was considered under the expedited review provisions of the President's Emergency Plan for AIDS Relief (Drug Industry Daily, 6/30).

FDA Grants Conditional Approval To Interventional Spine's PercuDyn System IDE Application (Medical News Today)
Interventional Spine, Inc. announced that the U.S. Food and Drug Administration has approved the Company's investigational device exemption (IDE) application for its PercuDyn System for the treatment of degenerative disc disease (DDD). This approval is conditional upon the Company providing some additional information to the FDA. Walter A.

Crystalens HD Receives FDA Approval (Medical News Today)
Bausch & Lomb announced that it has received approval from the Food and Drug Administration (FDA) to market the Crystalens HD in the United States. Crystalens accommodating intraocular lens (IOL) was first approved by the FDA in November 2003. The Crystalens HD is the fourth generation of the only FDA approved accommodating lens.